PMC:2944646 / 26972-27673 JSONTXT

{"project":"TEST0","denotations":[{"id":"20877425-41-49-198963","span":{"begin":558,"end":562},"obj":"[\"20218980\"]"}],"text":"Figure 4 Piracetam improves neuritogenesis following Aß exposure. (A) PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence of oligomeric Aβ 1 μM. Piracetam 1 mM was added and the effects on neurite outgrowth were investigated. (B) APPsw PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence or absence of piracetam 1 mM and neurite outgrowth was measured. In the presence of different NGF concentrations (1–50 ng/ml) piracetam improved the neurotrophic effect of NGF in APPsw cells. All data are modified after Kurz et al. (2010). Data are expressed as mean ± SEM (n = 6–7) **p \u003c 0.01, ***p \u003c 0.001 vs. the respective control, two-way anova with bonferroni post test."}

{"project":"0_colil","denotations":[{"id":"20877425-20218980-198963","span":{"begin":558,"end":562},"obj":"20218980"}],"text":"Figure 4 Piracetam improves neuritogenesis following Aß exposure. (A) PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence of oligomeric Aβ 1 μM. Piracetam 1 mM was added and the effects on neurite outgrowth were investigated. (B) APPsw PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence or absence of piracetam 1 mM and neurite outgrowth was measured. In the presence of different NGF concentrations (1–50 ng/ml) piracetam improved the neurotrophic effect of NGF in APPsw cells. All data are modified after Kurz et al. (2010). Data are expressed as mean ± SEM (n = 6–7) **p \u003c 0.01, ***p \u003c 0.001 vs. the respective control, two-way anova with bonferroni post test."}

{"project":"2_test","denotations":[{"id":"20877425-20218980-38148056","span":{"begin":558,"end":562},"obj":"20218980"}],"text":"Figure 4 Piracetam improves neuritogenesis following Aß exposure. (A) PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence of oligomeric Aβ 1 μM. Piracetam 1 mM was added and the effects on neurite outgrowth were investigated. (B) APPsw PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence or absence of piracetam 1 mM and neurite outgrowth was measured. In the presence of different NGF concentrations (1–50 ng/ml) piracetam improved the neurotrophic effect of NGF in APPsw cells. All data are modified after Kurz et al. (2010). Data are expressed as mean ± SEM (n = 6–7) **p \u003c 0.01, ***p \u003c 0.001 vs. the respective control, two-way anova with bonferroni post test."}